TwoStep Therapeutics
Private
Clinical-stage oncology company developing tumor-targeting therapeutics for solid tumors using its PIP agent platform that targets integrins on solid tumor tissue.
Company Info
Sector:Drug Delivery/Formulation
Headquarters:San Diego, California, United States
Founded:2020
Website:twosteptx.com/
Funding Round:Series B
Total Funding:$62.5M
Upcoming Milestones & Key Dates
2026-09-09
Financing
$62.5M funding announced to advance ADC twist into clinic
Clinical Development Pipeline
PIP Agent Platform
Target: IntegrinsRecent News
No recent news updates available for this company.